Defibrillator Function and Implantation

  • Robert E. Eckart
  • Jane Chen
  • Laurence M. Epstein

The development of the implantable cardioverter-defibrillator (ICD) is primarily the result of pioneering work by Michel Mirowski. First-generation devices consisted of a large generator placed in an abdominal pocket capable only of high-energy shocks. In the 25 years since the first implantation in humans (1), advances in technology have resulted in significantly smaller devices, with sophisticated detection algorithms and tiered therapies. Despite these advances, the primary goal of the ICD continues to be the rapid and effective treatment of ventricular arrhythmias.


Ventricular Tachycardia Right Ventricle Implantable Cardioverter Defibrillator Superior Vena Cava Right Atrium 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Mirowski M, Mower MM, Reid PR. The automatic implantable defibrillator. Am Heart J 1980;100:1089–92.PubMedCrossRefGoogle Scholar
  2. 2.
    Mirowski M, Reid PR, Mower MM, Watkins L, Gott VL, Schauble JF, Langer A, Heilman MS, Kolenik SA, Fischell RE, Weisfeldt ML. Termination of malignant ventricular arrhythmias with an implanted automatic defibrillator in human beings. N Engl J Med 1980;303:322–4.PubMedGoogle Scholar
  3. 3.
    Fitzpatrick AP, Lesh MD, Epstein LM, Lee RJ, Siu A, Merrick S, Griffin JC, Scheinman MM. Electrophysiological laboratory, electrophysiologist-implanted, nonthoracotomy-implantable cardioverter/defibrillators. Circulation 1994;89:2503–8.PubMedGoogle Scholar
  4. 4.
    Natale A, Kearney MM, Brandon MJ, Kent V, Wase A, Newby KH, Pisano E, Geiger MJ. Safety of nurse-administered deep sedation for defibrillator implantation in the electrophysiology laboratory. J Cardiovasc Electrophysiol 1996;7:301–6.PubMedCrossRefGoogle Scholar
  5. 5.
    Buxton AE, Lee KL, Fisher JD, Josephson ME, Prystowsky EN, Hafley G. A randomized study of the prevention of sudden death in patients with coronary artery disease. Multicenter Unsustained Tachycardia Trial Investigators. N Engl J Med 1999;341:1882–90.CrossRefGoogle Scholar
  6. 6.
    Moss AJ, Hall WJ, Cannom DS, Daubert JP, Higgins SL, Klein H, Levine JH, Saksena S, Waldo AL, Wilber D, Brown MW, Heo M. Improved survival with an implanted defibrillator in patients with coronary disease at high risk for ventricular arrhythmia. Multicenter Automatic Defibrillator Implantation Trial Investigators. N Engl J Med 1996;335:1933–40.CrossRefGoogle Scholar
  7. 7.
    Moss AJ, Zareba W, Hall WJ, Klein H, Wilber DJ, Cannom DS, Daubert JP, Higgins SL, Brown MW, Andrews ML. Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction. N Engl J Med 2002;346:877–83.PubMedCrossRefGoogle Scholar
  8. 8.
    Bardy GH, Lee KL, Mark DB, Poole JE, Packer DL, Boineau R, Domanski M, Troutman C, Anderson J, Johnson G, McNulty SE, Clapp-Channing N, Davidson-Ray LD, Fraulo ES, Fishbein DP, Luceri RM, Ip JH. Amiodarone or an implantable cardioverter-defibrillator for congestive heart failure. N Engl J Med 2005;352:225–37.PubMedCrossRefGoogle Scholar
  9. 9.
    AVID. A comparison of antiarrhythmic-drug therapy with implantable defibrillators in patients resuscitated from near-fatal ventricular arrhythmias. The Antiarrhythmics versus Implantable Defibrillators (AVID) Investigators. N Engl J Med 1997;337:1576–83.CrossRefGoogle Scholar
  10. 10.
    Connolly SJ, Gent M, Roberts RS, Dorian P, Roy D, Sheldon RS, Mitchell LB, Green MS, Klein GJ, O’Brien B. Canadian implantable defibrillator study (CIDS): a randomized trial of the implantable cardioverter defibrillator against amiodarone. Circulation 2000;101:1297–302.PubMedGoogle Scholar
  11. 11.
    Kuck KH, Cappato R, Siebels J, Ruppel R. Randomized comparison of antiarrhythmic drug therapy with implantable defibrillators in patients resuscitated from cardiac arrest: the Cardiac Arrest Study Hamburg (CASH). Circulation 2000;102:748–54.PubMedGoogle Scholar
  12. 12.
    Gold MR, Shorofsky SR, Thompson JA, Kim J, Schwartz M, Bocek J, Lovett EG, Hsu W, Morris MM, Lang DJ. Advanced rhythm discrimination for implantable cardioverter defibrillators using electrogram vector timing and correlation. J Cardiovasc Electrophysiol 2002;13:1092–7.PubMedCrossRefGoogle Scholar
  13. 13.
    Glikson M, Swerdlow CD, Gurevitz OT, Daoud E, Shivkumar K, Wilkoff B, Shipman T, Friedman PA. Optimal combination of discriminators for differentiating ventricular from supraventricular tachycardia by dual-chamber defibrillators. J Cardiovasc Electrophysiol 2005;16:732–9.PubMedCrossRefGoogle Scholar
  14. 14.
    Compton SJ, Merrill JJ, Dorian P, Cao J, Zhou D, Gillberg JM. Continuous template collection and updating for electrogram morphology discrimination in implantable cardioverter defibrillators. Pacing Clin Electrophysiol 2006;29:244–54.PubMedCrossRefGoogle Scholar
  15. 15.
    Sweeney MO, Wathen MS, Volosin K, Abdalla I, DeGroot PJ, Otterness MF, Stark AJ. Appropriate and inappropriate ventricular therapies, quality of life, and mortality among primary and secondary prevention implantable cardioverter defibrillator patients: results from the Pacing Fast VT REduces Shock ThErapies (PainFREE Rx II) trial. Circulation 2005;111:2898–905.PubMedCrossRefGoogle Scholar
  16. 16.
    Wathen MS, DeGroot PJ, Sweeney MO, Stark AJ, Otterness MF, Adkisson WO, Canby RC, Khalighi K, Machado C, Rubenstein DS, Volosin KJ. Prospective randomized multicenter trial of empirical antitachycardia pacing versus shocks for spontaneous rapid ventricular tachycardia in patients with implantable cardioverter-defibrillators: Pacing Fast Ventricular Tachycardia Reduces Shock Therapies (PainFREE Rx II) trial results. Circulation 2004;110:2591–6.PubMedCrossRefGoogle Scholar
  17. 17.
    Guidant. Factors that affect ICD longevity and replacement time Guidant Corporation Cardiac Rhythm Management–Product Update. St. Paul, MN, 2003.Google Scholar
  18. 18.
    Medtronic. CRM Product Performance Report. Minneapolis, MN, 2006.Google Scholar
  19. 19.
    SJM. CRM Product Performance Report. St. Paul, MN, 2006.Google Scholar
  20. 20.
    Guidant. CRM Product Performance Report. Guidant Corporation. St. Paul, MN, 2006.Google Scholar
  21. 21.
    Crespi A, Schmidt C, Norton J, Chen K, Skarstad P. Modeling and characterization of the resistance of lithium/SVO batteries for implantable cardioverter defibrillators. J Electrochem Soc 2001;148:A30–37.CrossRefGoogle Scholar
  22. 22.
    Guidant. ERI Charge Time Limit Extended During Mid-Life in ICDs and CRT-Ds. Guidant Corporation Cardiac Rhythm Management–Product Update. St. Paul, MN, 2006.Google Scholar
  23. 23.
    Crespi A, Somdahl S, Hokanson K, Jain M, Skarstad P. Lithium-limited batteries for implantable cardioverter-defibrillators 202nd Meeting–The Electrochemical Society. Salt Lake City, UT, 2002.Google Scholar
  24. 24.
    Huffman FN, Migliore JJ, Robinson WJ, Norman JC. Radioisotope powered cardiac pacemakers. Cardiovasc Dis 1974;1:52–60.PubMedGoogle Scholar
  25. 25.
    Parsonnet V, Berstein AD, Perry GY. The nuclear pacemaker: is renewed interest warranted? Am J Cardiol 1990;66:837–42.PubMedCrossRefGoogle Scholar
  26. 26.
    Mitcheson PD, Green TC, Yeatman EM, Holmes AS. Architectures for vibration-driven micropower generators. J Microelectromech Syst 2004;13:429–40.CrossRefGoogle Scholar
  27. 27.
    Ozeki T, Chinzei T, Abe Y, Saito I, Isoyama T, Ono T, Kouno A, Ishimaru M, Takiura K, Baba A, Toyama T, Imachi K. A study on an energy supply method for a transcutaneous energy transmission system. Artif Organs 2003;27:68–72.PubMedCrossRefGoogle Scholar
  28. 28.
    Tchin-Iou AV, Min BG. Design of the solar cell system for recharging the external battery of the totally-implantable artificial heart. Int J Artif Organs 1999;22:823–6.PubMedGoogle Scholar
  29. 29.
    Goto K, Nakagawa T, Nakamura O, Kawata S. An implantable power supply with an optically rechargeable lithium battery. IEEE Trans Biomed Eng 2001;48:830–3.PubMedCrossRefGoogle Scholar
  30. 30.
    Langer A, Heilman MS, Mower MM, Mirowski M. Considerations in the development of the automatic implantable defibrillator. Med Instrum 1976;10:163–7.PubMedGoogle Scholar
  31. 31.
    Toivonen L, Viitasalo M, Jarvinen A. The performance of the probability density function in differentiating supraventricular from ventricular rhythms. Pacing Clin Electrophysiol 1992;15:726–30.PubMedCrossRefGoogle Scholar
  32. 32.
    Aubert AE, Denys BG, Ector H, De Geest H. Detection of ventricular tachycardia and fibrillation using ECG processing and intramyocardial pressure gradients. Pacing Clin Electrophysiol 1986;9:1084–8.PubMedCrossRefGoogle Scholar
  33. 33.
    Polikaitis A, Arzbaecher R, Bump T, Wilber D. Probability density function revisited: improved discrimination of VF using a cycle length corrected PDF. Pacing Clin Electrophysiol 1997;20:1947–51.PubMedCrossRefGoogle Scholar
  34. 34.
    Winkle RA, Bach SM, Jr., Echt DS, Swerdlow CD, Imran M, Mason JW, Oyer PE, Stinson EB. The automatic implantable defibrillator: local ventricular bipolar sensing to detect ventricular tachycardia and fibrillation. Am J Cardiol 1983;52:265–70.PubMedCrossRefGoogle Scholar
  35. 35.
    Dijkman B, Wellens HJ. Dual chamber arrhythmia detection in the implantable cardioverter defibrillator. J Cardiovasc Electrophysiol 2000;11:1105–15.PubMedCrossRefGoogle Scholar
  36. 36.
    Olsen WH. Tachyarrhythmia sensing and detection. In: Singer I, ed. Implantable cardioverter defibrillator. Armonk, NY: Futura Publishing, 1994:777.Google Scholar
  37. 37.
    Berul CI, Callans DJ, Schwartzman DS, Preminger MW, Gottlieb CD, Marchlinski FE. Comparison of initial detection and redetection of ventricular fibrillation in a transvenous defibrillator system with automatic gain control. J Am Coll Cardiol 1995;25:431–6.PubMedCrossRefGoogle Scholar
  38. 38.
    Niehaus M, Neuzner J, Vogt J, Korte T, Tebbenjohanns J. Adjustment of maximum automatic sensitivity (automatic gain control) reduces inappropriate therapies in patients with implantable cardioverter defibrillators. Pacing Clin Electrophysiol 2002;25:151–5.PubMedCrossRefGoogle Scholar
  39. 39.
    Swerdlow CD, Friedman PA. Advanced ICD troubleshooting: Part I. Pacing Clin Electrophysiol 2005;28:1322–46.PubMedCrossRefGoogle Scholar
  40. 40.
    Chugh A, Scharf C, Hall B, Cheung P, Good E, Horwood L, Oral H, Pelosi F, Jr., Morady F. Prevalence and management of inappropriate detection and therapies in patients with first-generation biventricular pacemaker-defibrillators. Pacing Clin Electrophysiol 2005;28:44–50.PubMedCrossRefGoogle Scholar
  41. 41.
    Brodman R, Fisher JD, Furman S, Johnston DR, Kim SG, Matos JA, Waspe LE. Implantation of automatic cardioverter-defibrillators via median sternotomy. Pacing Clin Electrophysiol 1984;7:1363–9.PubMedCrossRefGoogle Scholar
  42. 42.
    Ideker RE, Wolf PD, Alferness C, Krassowska W, Smith WM. Current concepts for selecting the location, size and shape of defibrillation electrodes. Pacing Clin Electrophysiol 1991;14:227–40.PubMedCrossRefGoogle Scholar
  43. 43.
    Molina JE, Benditt DG, Adler S. Crinkling of epicardial defibrillator patches. A common and serious problem. J Thorac Cardiovasc Surg 1995;110:258–64.Google Scholar
  44. 44.
    Saksena S. Defibrillation thresholds and perioperative mortality associated with endocardial and epicardial defibrillation lead systems. The PCD investigators and participating institutions. Pacing Clin Electrophysiol 1993;16:202–7.Google Scholar
  45. 45.
    Chevalier P, Moncada E, Canu G, Claudel JP, Bellon C, Kirkorian G, Touboul P. Symptomatic pericardial disease associated with patch electrodes of the automatic implantable cardioverter defibrillator: an underestimated complication? Pacing Clin Electrophysiol 1996;19:2150–2.PubMedCrossRefGoogle Scholar
  46. 46.
    Reid PR, Mirowski M, Mower MM, Platia EV, Griffith LS, Watkins L, Jr., Bach SM, Jr., Imran M, Thomas A. Clinical evaluation of the internal automatic cardioverter-defibrillator in survivors of sudden cardiac death. Am J Cardiol 1983;51:1608–13.PubMedCrossRefGoogle Scholar
  47. 47.
    BInner L, Stiller S, Brummer T, Stiller P, Grossmann G. Single coil ICD leads allow safe routine ICD implantation. [Abstract]. Europace 2005;7:93.Google Scholar
  48. 48.
    Rub N, Schweitzer O, Mewis C, Kettering K, Kuehlkamp V. Addition of a defibrillation electrode in the low right atrium to a right ventricular lead does not reduce ventricular defibrillation thresholds. Pacing Clin Electrophysiol 2004;27:346–51.PubMedCrossRefGoogle Scholar
  49. 49.
    Bardy GH, Allen MD, Mehra R, Johnson G. An effective and adaptable transvenous defibrillation system using the coronary sinus in humans. J Am Coll Cardiol 1990;16:887–95.PubMedCrossRefGoogle Scholar
  50. 50.
    Usui M, Walcott GP, Strickberger SA, Rollins DL, Smith WM, Ideker RE. Effects of polarity for monophasic and biphasic shocks on defibrillation efficacy with an endocardial system. Pacing Clin Electrophysiol 1996;19:65–71.PubMedCrossRefGoogle Scholar
  51. 51.
    Sweeney MO, Ellison KE, Shea JB, Newell JB. Provoked and spontaneous high-frequency, low-amplitude, respirophasic noise transients in patients with implantable cardioverter defibrillators. J Cardiovasc Electrophysiol 2001;12:402–10.PubMedCrossRefGoogle Scholar
  52. 52.
    Gradaus R, Breithardt G, Bocker D. ICD leads: design and chronic dysfunctions. Pacing Clin Electrophysiol 2003;26:649–57.PubMedCrossRefGoogle Scholar
  53. 53.
    Epstein AE, Kay GN, Plumb VJ, Dailey SM, Anderson PG. Gross and microscopic pathological changes associated with nonthoracotomy implantable defibrillator leads. Circulation 1998;98:1517–24.PubMedGoogle Scholar
  54. 54.
    Wilkoff BL, Belott PH, Love CJ, Scheiner A, Westlund R, Rippy M, Krishnan M, Norlander BE, Steinhaus B, Emmanuel J, Zeller PJ. Improved extraction of ePTFE and medical adhesive modified defibrillation leads from the coronary sinus and great cardiac vein. Pacing Clin Electrophysiol 2005;28:205–11.PubMedCrossRefGoogle Scholar
  55. 55.
    Germano JJ, Reynolds M, Essebag V, Josephson ME. Frequency and causes of implantable cardioverter-defibrillator therapies: is device therapy proarrhythmic? Am J Cardiol 2006;97:1255–61.PubMedCrossRefGoogle Scholar
  56. 56.
    Grimm W, Flores BF, Marchlinski FE. Electrocardiographically documented unnecessary, spontaneous shocks in 241 patients with implantable cardioverter defibrillators. Pacing Clin Electrophysiol 1992;15:1667–73.PubMedCrossRefGoogle Scholar
  57. 57.
    Gronefeld GC, Schulte B, Hohnloser SH, Trappe HJ, Korte T, Stellbrink C, Jung W, Meesmann M, Bocker D, Grosse-Meininghaus D, Vogt J. Morphology discrimination: a beat-to-beat algorithm for the discrimination of ventricular from supraventricular tachycardia by implantable cardioverter defibrillators. Pacing Clin Electrophysiol 2001;24:1519–24.PubMedCrossRefGoogle Scholar
  58. 58.
    Swerdlow CD, Chen PS, Kass RM, Allard JR, Peter CT. Discrimination of ventricular tachycardia from sinus tachycardia and atrial fibrillation in a tiered-therapy cardioverter-defibrillator. J Am Coll Cardiol 1994;23:1342–55.PubMedCrossRefGoogle Scholar
  59. 59.
    Swerdlow CD, Ahern T, Chen PS, Hwang C, Gang E, Mandel W, Kass RM, Peter CT. Underdetection of ventricular tachycardia by algorithms to enhance specificity in a tiered-therapy cardioverter-defibrillator. J Am Coll Cardiol 1994;24:416–24.PubMedGoogle Scholar
  60. 60.
    Le Franc P, Kus T, Vinet A, Rocque P, Molin F, Costi P. Underdetection of ventricular tachycardia using a 40 ms stability criterion: effect of antiarrhythmic therapy. Pacing Clin Electrophysiol 1997;20:2882–92.PubMedCrossRefGoogle Scholar
  61. 61.
    Goldberger Z, Elbel B, McPherson CA, Paltiel AD, Lampert R. Cost advantage of dual-chamber versus single-chamber cardioverter-defibrillator implantation. J Am Coll Cardiol 2005;46:850–7.PubMedCrossRefGoogle Scholar
  62. 62.
    Dorian P, Philippon F, Thibault B, Kimber S, Sterns L, Greene M, Newman D, Gelaznikas R, Barr A. Randomized controlled study of detection enhancements versus rate-only detection to prevent inappropriate therapy in a dual-chamber implantable cardioverter-defibrillator. Heart Rhythm 2004;1:540–7.PubMedCrossRefGoogle Scholar
  63. 63.
    Theuns DA, Klootwijk AP, Goedhart DM, Jordaens LJ. Prevention of inappropriate therapy in implantable cardioverter-defibrillators: results of a prospective, randomized study of tachyarrhythmia detection algorithms. J Am Coll Cardiol 2004;44:2362–7.PubMedCrossRefGoogle Scholar
  64. 64.
    Aliot E, Nitzsche R, Ripart A. Arrhythmia detection by dual-chamber implantable cardioverter defibrillators. A review of current algorithms. Europace 2004;6:273–86.CrossRefGoogle Scholar
  65. 65.
    Sweeney MO, Ellenbogen KA, Casavant D, Betzold R, Sheldon T, Tang F, Mueller M, Lingle J. Multicenter, prospective, randomized safety and efficacy study of a new atrial-based managed ventricular pacing mode (MVP) in dual chamber ICDs. J Cardiovasc Electrophysiol 2005;16:811–7.PubMedCrossRefGoogle Scholar
  66. 66.
    Wilkoff BL, Cook JR, Epstein AE, Greene HL, Hallstrom AP, Hsia H, Kutalek SP, Sharma A. Dual-chamber pacing or ventricular backup pacing in patients with an implantable defibrillator: the Dual Chamber and VVI Implantable Defibrillator (DAVID) Trial. JAMA 2002;288:3115–23.PubMedCrossRefGoogle Scholar
  67. 67.
    Zhou X, Daubert JP, Wolf PD, Smith WM, Ideker RE. Epicardial mapping of ventricular defibrillation with monophasic and biphasic shocks in dogs. Circ Res 1993;72:145–60.PubMedGoogle Scholar
  68. 68.
    Chen PS, Shibata N, Dixon EG, Martin RO, Ideker RE. Comparison of the defibrillation threshold and the upper limit of ventricular vulnerability. Circulation 1986;73:1022–8.PubMedGoogle Scholar
  69. 69.
    Glikson M, Gurevitz OT, Trusty JM, Sharma V, Luria DM, Eldar M, Shen WK, Rea RF, Hammill SC, Friedman PA. Upper limit of vulnerability determination during implantable cardioverter-defibrillator placement to minimize ventricular fibrillation inductions. Am J Cardiol 2004;94:1445–9.PubMedCrossRefGoogle Scholar
  70. 70.
    Singer I, Lang D. Defibrillation threshold: clinical utility and therapeutic implications. Pacing Clin Electrophysiol 1992;15:932–49.PubMedCrossRefGoogle Scholar
  71. 71.
    Fain ES, Dorian P, Davy JM, Kates RE, Winkle RA. Effects of encainide and its metabolites on energy requirements for defibrillation. Circulation 1986;73:1334–41.PubMedGoogle Scholar
  72. 72.
    Reiffel JA, Coromilas J, Zimmerman JM, Spotnitz HM. Drug-device interactions: clinical considerations. Pacing Clin Electrophysiol 1985;8:369–73.PubMedCrossRefGoogle Scholar
  73. 73.
    Dorian P, Fain ES, Davy JM, Winkle RA. Lidocaine causes a reversible, concentration-dependent increase in defibrillation energy requirements. J Am Coll Cardiol 1986;8:327–32.PubMedCrossRefGoogle Scholar
  74. 74.
    Marinchak RA, Friehling TD, Kline RA, Stohler J, Kowey PR. Effect of antiarrhythmic drugs on defibrillation threshold: case report of an adverse effect of mexiletine and review of the literature. Pacing Clin Electrophysiol 1988;11:7–12.PubMedCrossRefGoogle Scholar
  75. 75.
    Huang J, Skinner JL, Rogers JM, Smith WM, Holman WL, Ideker RE. The effects of acute and chronic amiodarone on activation patterns and defibrillation threshold during ventricular fibrillation in dogs. J Am Coll Cardiol 2002;40:375–83.PubMedCrossRefGoogle Scholar
  76. 76.
    Guarnieri T, Levine JH, Veltri EP, Griffith LS, Watkins L, Jr., Juanteguy J, Mower MM, Mirowski M. Success of chronic defibrillation and the role of antiarrhythmic drugs with the automatic implantable cardioverter/defibrillator. Am J Cardiol 1987;60:1061–4.PubMedCrossRefGoogle Scholar
  77. 77.
    Movsowitz C, Marchlinski FE. Interactions between implantable cardioverter-defibrillators and class III agents. Am J Cardiol 1998;82:41I–8I.PubMedCrossRefGoogle Scholar
  78. 78.
    Yabe S, Smith WM, Daubert JP, Wolf PD, Rollins DL, Ideker RE. Conduction disturbances caused by high current density electric fields. Circ Res 1990;66:1190–203.PubMedGoogle Scholar
  79. 79.
    Jones JL, Jones RE, Balasky G. Microlesion formation in myocardial cells by high-intensity electric field stimulation. Am J Physiol 1987;253:H480–6.PubMedGoogle Scholar
  80. 80.
    Zoll PM, Paul MH, Linenthal AJ, Norman LR, Gibson W. The effect of external electric currents on the heart; control of cardiac rhythm and induction and termination of cardiac arrhythmias. Circulation 1956;14:745–56.PubMedGoogle Scholar
  81. 81.
    Lown B, Neuman J, Amarasingham R, Berkovits BV. Comparison of alternating current with direct electroshock across the closed chest. Am J Cardiol 1962;10:223–33.PubMedCrossRefGoogle Scholar
  82. 82.
    Jones DL, Sohla A, Bourland JD, Tacker WA, Kallok MJ, Klein GJ. Internal ventricular defibrillation with sequential pulse countershock in pigs: comparison with single pulses and effects of pulse separation. Pacing Clin Electrophysiol 1987;10:497–502.PubMedCrossRefGoogle Scholar
  83. 83.
    Jones DL, Klein GJ, Rattes MF, Sohla A, Sharma AD. Internal cardiac defibrillation: single and sequential pulses and a variety of lead orientations. Pacing Clin Electrophysiol 1988;11:583–91.PubMedCrossRefGoogle Scholar
  84. 84.
    Block M, Hammel D, Bocker D, Borggrefe M, Budde T, Isbruch F, Wietholt D, Scheld HH, Breithardt G. A prospective randomized cross-over comparison of mono- and biphasic defibrillation using nonthoracotomy lead configurations in humans. J Cardiovasc Electrophysiol 1994;5:581–90.PubMedCrossRefGoogle Scholar
  85. 85.
    Irnich W. How to program pulse duration or tilt in implantable cardioverter defibrillators. Pacing Clin Electrophysiol 2003;26:453–6.PubMedCrossRefGoogle Scholar
  86. 86.
    Shepard RK, DeGroot PJ, Pacifico A, Wood MA, Ellenbogen KA. Prospective randomized comparison of 65%/65% versus 42%/42% tilt biphasic waveform on defibrillation thresholds in humans. J Interv Card Electrophysiol 2003;8:221–5.PubMedCrossRefGoogle Scholar
  87. 87.
    Sweeney MO, Natale A, Volosin KJ, Swerdlow CD, Baker JH, Degroot P. Prospective randomized comparison of 50%/50% versus 65%/65% tilt biphasic waveform on defibrillation in humans. Pacing Clin Electrophysiol 2001;24:60–5.PubMedCrossRefGoogle Scholar
  88. 88.
    Huang J, KenKnight BH, Rollins DL, Smith WM, Ideker RE. Ventricular vdefibrillation with triphasic waveforms. Circulation 2000;101:1324–8.PubMedGoogle Scholar
  89. 89.
    Zhang Y, Boddicker KA, Davies LR, Jones JL, Kerber RE. Surgical open-chest ventricular defibrillation: triphasic waveforms are superior to biphasic waveforms. Pacing Clin Electrophysiol 2004;27:941–8.PubMedCrossRefGoogle Scholar
  90. 90.
    Lok NS, Lau CP, Tse HF, Ayers GM. Clinical shock tolerability and effect of different right atrial electrode locations on efficacy of low energy human transvenous atrial defibrillation using an implantable lead system. J Am Coll Cardiol 1997;30:1324–30.PubMedCrossRefGoogle Scholar
  91. 91.
    Jung J, Hahn SJ, Heisel A, Buob A, Schubert BD, Siaplaouras S. Defibrillation efficacy and pain perception of two biphasic waveforms for internal cardioversion of atrial fibrillation. J Cardiovasc Electrophysiol 2003;14:837–40.PubMedCrossRefGoogle Scholar
  92. 92.
    Chattipakorn N, Banville I, Gray RA, Ideker RE. Effects of shock strengths on ventricular defibrillation failure. Cardiovasc Res 2004;61:39–44.PubMedCrossRefGoogle Scholar
  93. 93.
    Wathen MS, Sweeney MO, DeGroot PJ, Stark AJ, Koehler JL, Chisner MB, Machado C, Adkisson WO. Shock reduction using antitachycardia pacing for spontaneous rapid ventricular tachycardia in patients with coronary artery disease. Circulation 2001;104:796–801.PubMedCrossRefGoogle Scholar
  94. 94.
    Stevenson WG, Friedman PL, Sager PT, Saxon LA, Kocovic D, Harada T, Wiener I, Khan H. Exploring postinfarction reentrant ventricular tachycardia with entrainment mapping. J Am Coll Cardiol 1997;29:1180–9.PubMedCrossRefGoogle Scholar
  95. 95.
    Stevenson WG, Khan H, Sager P, Saxon LA, Middlekauff HR, Natterson PD, Wiener I. Identification of reentry circuit sites during catheter mapping and radiofrequency ablation of ventricular tachycardia late after myocardial infarction. Circulation 1993;88:1647–70.PubMedGoogle Scholar
  96. 96.
    Almendral JM, Rosenthal ME, Stamato NJ, Marchlinski FE, Buxton AE, Frame LH, Miller JM, Josephson ME. Analysis of the resetting phenomenon in sustained uniform ventricular tachycardia: incidence and relation to termination. J Am Coll Cardiol 1986;8:294–300.PubMedCrossRefGoogle Scholar
  97. 97.
    Cook JR, Kirchhoffer JB, Fitzgerald TF, Lajzer DA. Comparison of decremental and burst overdrive pacing as treatment for ventricular tachycardia associated with coronary artery disease. Am J Cardiol 1992;70:311–5.PubMedCrossRefGoogle Scholar
  98. 98.
    Newman D, Dorian P, Hardy J. Randomized controlled comparison of antitachycardia pacing algorithms for termination of ventricular tachycardia. J Am Coll Cardiol 1993;21:1413–8.PubMedCrossRefGoogle Scholar
  99. 99.
    Gold MR, Peters RW, Johnson JW, Shorofsky SR. Complications associated with pectoral cardioverter-defibrillator implantation: comparison of subcutaneous and submuscular approaches. Worldwide Jewel Investigators. J Am Coll Cardiol 1996;28:1278–82.CrossRefGoogle Scholar
  100. 100.
    Pacifico A, Wheelan KR, Nasir N, Jr., Wells PJ, Doyle TK, Johnson SA, Henry PD. Long-term follow-up of cardioverter-defibrillator implanted under conscious sedation in prepectoral subfascial position. Circulation 1997;95:946–50.PubMedGoogle Scholar
  101. 101.
    van Rugge FP, Savalle LH, Schalij MJ. Subcutaneous single-incision implantation of cardioverter-defibrillators under local anesthesia by electrophysiologists in the electrophysiology laboratory. Am J Cardiol 1998;81:302–5.PubMedCrossRefGoogle Scholar
  102. 102.
    Tobin K, Stewart J, Westveer D, Frumin H. Acute complications of permanent pacemaker implantation: their financial implication and relation to volume and operator experience. Am J Cardiol 2000;85:774–6, A9.CrossRefGoogle Scholar
  103. 103.
    Pavia S, Wilkoff B. The management of surgical complications of pacemaker and implantable cardioverter-defibrillators. Curr Opin Cardiol 2001;16:66–71.PubMedCrossRefGoogle Scholar
  104. 104.
    Gurevitz OT, Friedman PA, Glikson M, Trusty JM, Ballman KV, Rosales AG, Hayes DL, Hammill SC, Swerdlow CD. Discrepancies between the upper limit of vulnerability and defibrillation threshold: prevalence and clinical predictors. J Cardiovasc Electrophysiol 2003;14:728–32.PubMedGoogle Scholar
  105. 105.
    Green UB, Garg A, Al-Kandari F, Ungab G, Tone L, Feld GK. Successful implantation of cardiac defibrillators without induction of ventricular fibrillation using upper limit of vulnerability testing. J Interv Card Electrophysiol 2003;8:71–5.PubMedCrossRefGoogle Scholar
  106. 106.
    Swerdlow CD, Peter CT, Kass RM, Gang ES, Mandel WJ, Hwang C, Martin DJ, Chen PS. Programming of implantable cardioverter-defibrillators on the basis of the upper limit of vulnerability. Circulation 1997;95:1497–504.PubMedGoogle Scholar
  107. 107.
    Gradaus R, Block M, Seidl K, Brunn J, Isgro F, Hammel D, Hauer B, Breithardt G, Bocker D. Defibrillation efficacy comparing a subcutaneous array electrode versus an “active can” implantable cardioverter defibrillator and a subcutaneous array electrode in addition to an “active can” implantable cardioverter defibrillator: results from active can versus array trials I and II. J Cardiovasc Electrophysiol 2001;12:921–7.PubMedCrossRefGoogle Scholar
  108. 108.
    Kuhlkamp V, Dornberger V, Mewis C, Seipel L. Comparison of the efficacy of a subcutaneous array electrode with a subcutaneous patch electrode, a prospective randomized study. Int J Cardiol 2001;78:247–56.PubMedCrossRefGoogle Scholar
  109. 109.
    Da Costa A, Kirkorian G, Cucherat M, Delahaye F, Chevalier P, Cerisier A, Isaaz K, Touboul P. Antibiotic prophylaxis for permanent pacemaker implantation: a meta-analysis. Circulation 1998;97:1796–801.PubMedGoogle Scholar
  110. 110.
    Goldberger JJ, Horvath G, Inbar S, Kadish AH. Utility of predischarge and one-month transvenous implantable defibrillator tests. Am J Cardiol 1997;79:822–6.PubMedCrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media, LLC 2008

Authors and Affiliations

  • Robert E. Eckart
    • 1
  • Jane Chen
    • 2
  • Laurence M. Epstein
    • 3
  1. 1.Tripler Army Medical CenterHawaii
  2. 2.Washington University School of MedicineSt. LouisUSA
  3. 3.Chief, Arrhythmia ServiceBrigham and Women's HospitalBostonUSA

Personalised recommendations